cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Thermo Fisher Scientific Inc
171 own
66 watching
Current Price
$501.6
$-4.06
(-0.8%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
198,742.89M
52-Week High
52-Week High
609.84998
52-Week Low
52-Week Low
475.76999
Average Volume
Average Volume
0.98M
Dividend Yield
Dividend Yield
0.001621
P/E Ratio
P/E Ratio
28.5896
iconMarket Capitalization198,742.89M
icon52-Week High609.84998
icon52-Week Low475.76999
iconAverage Volume0.98M
iconDividend Yield0.001621
iconP/E Ratio28.5896
What does the Thermo Fisher Scientific Inc do?
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems to support clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers controlled temperature technology products; sample preparation and preservation equipment; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; and research and safety market channel, and biopharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Read More
How much money does Thermo Fisher Scientific Inc make?
News & Events about Thermo Fisher Scientific Inc.
Business Wire
2 months ago
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2023 before the market opens on Wednesday, July 26, 2023, and will hold a conference call on the same day at 8:30 a.m. EDT. During the...
Zolmax
3 months ago
Hills Bank & Trust Co cut its stake in Thermo Fisher Scientific Inc. (NYSE:TMO Get Rating) by 1.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,890 shares of the medical research companys stock ...
Zolmax
3 months ago
Romano Brothers AND Company grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO Get Rating) by 3.9% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 941 shares of the medical research companys ...
Zolmax
3 months ago
HB Wealth Management LLC raised its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO Get Rating) by 3.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,390 shares of the medical research companys stock after purchasing an ...
Ticker Report
3 months ago
Romano Brothers AND Company grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO Get Rating) by 3.9% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 941 shares of the medical research ...
Frequently Asked Questions
Frequently Asked Questions
What is Thermo Fisher Scientific Inc share price today?
plus_minus_icon
Can Indians buy Thermo Fisher Scientific Inc shares?
plus_minus_icon
How can I buy Thermo Fisher Scientific Inc shares from India?
plus_minus_icon
Can Fractional shares of Thermo Fisher Scientific Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Thermo Fisher Scientific Inc stocks?
plus_minus_icon
What is today’s traded volume of Thermo Fisher Scientific Inc?
plus_minus_icon
What is today’s market capitalisation of Thermo Fisher Scientific Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Thermo Fisher Scientific Inc?
plus_minus_icon
What percentage is Thermo Fisher Scientific Inc down from its 52-Week High?
plus_minus_icon
What percentage is Thermo Fisher Scientific Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$501.6
$-4.06
(-0.8%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Stryker Corporation
Stryker Corporation
$273.54
$-13.84 (-4.82 %)
Medtronic PLC
Medtronic PLC
$78.95
$-1.02 (-1.28 %)
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
$70.38
$0.92 (1.32 %)
Becton, Dickinson and Company
Becton, Dickinson and Company
$260.94
$-5.83 (-2.19 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Stryker Corporation
Stryker Corporation
$273.54
$-13.84 (-4.82 %)
Medtronic PLC
Medtronic PLC
$78.95
$-1.02 (-1.28 %)
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
$70.38
$0.92 (1.32 %)
Becton, Dickinson and Company
Becton, Dickinson and Company
$260.94
$-5.83 (-2.19 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00